Goodwin advised ETM-Electromatic, Inc. on the deal. ETM-Electromatic, Inc. announced its acquisition by a wholly-owned subsidiary of Teledyne Technologies Incorporated (NYSE:TDY). ETM, headquartered in Newark, California, designs...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Asher Biotherapeutics on the deal. Asher Biotherapeutics announced the closing of its Series B financing, which raised $108 million. The financing was led by...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Vedanta Biosciences on the deal. Vedanta Biosciences announced the closing of a $68 million Series D financing. The round was led by affiliates of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...
You must be a Standard 1 Year member to access this content.
